Back
NovoCure Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
NVCR
NovoCure Ltd.
Last Price:
$13.27
Seasonality Move:
-7.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing selling pressure, which indicates risk of future bearish movement.
NovoCure Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.24 | Sell |
| 20-day SMA: | 12.87 | Buy |
| 50-day SMA: | 12.5 | Buy |
| 200-day SMA: | 14.73 | Sell |
| 8-day EMA: | 13.14 | Sell |
| 20-day EMA: | 12.9 | Buy |
| 50-day EMA: | 12.75 | Buy |
| 200-day EMA: | 14.77 | Sell |
NovoCure Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 51.58 | Buy |
| Chaikin Money Flow: | -763015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.06 - 13.4) | Buy |
| Bollinger Bands (100): | (11.72 - 13.56) | Buy |
NovoCure Ltd. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovoCure Ltd. Stock
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 12.93 while NVCR 8-day simple moving average is 13.24, which is a Sell signal.
-
The stock price of NVCR is 12.93 while NovoCure Ltd. 20-day SMA is 12.87, which makes it a Buy.
-
NovoCure Ltd. 50-day simple moving average is 12.50 while NVCR share price is 12.93, making it a Buy technically.
-
NVCR stock price is 12.93 and NovoCure Ltd. 200-day simple moving average is 14.73, creating a Sell signal.
NVCR Technical Analysis vs Fundamental Analysis
Sell
45
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy or a Sell?
-
NovoCure Ltd. stock is rated a SellThe current NovoCure Ltd. [NVCR] share price is $12.93. The Score for NVCR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
NovoCure Ltd. Stock Info
Market Cap:
1.4B
Price in USD:
12.93
Share Volume:
1.1M
NovoCure Ltd. 52-Week Range
52-Week High:
31.17
52-Week Low:
10.70
Sell
45
NovoCure Ltd. (NVCR)
is a Sell
NovoCure Ltd. Share Price Forecast
-
What is the NovoCure Ltd. stock price today?The NovoCure Ltd. stock price is 12.93 USD today.
-
Will NVCR stock go up or go down?NovoCure Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is NovoCure Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure Ltd. is overvalued.
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 12.93 while NVCR 8-day exponential moving average is 13.14, which is a Sell signal.
-
The stock price of NVCR is 12.93 while NovoCure Ltd. 20-day EMA is 12.90, which makes it a Buy.
-
NovoCure Ltd. 50-day exponential moving average is 12.75 while NVCR share price is 12.93, making it a Buy technically.
-
NVCR stock price is 12.93 and NovoCure Ltd. 200-day simple moving average is 14.77, creating a Sell signal.
Fundamental Analysis of NovoCure Ltd.
Is NovoCure Ltd. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.40 per share.
Technical Analysis of NovoCure Ltd.
Should I short NovoCure Ltd. stock?
-
NVCR Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting NovoCure Ltd. is a Buy
-
NovoCure Ltd. Relative Strength Index (RSI) is 51.58, which suggest NovoCure Ltd. is overbought
-
The Bollinger Bands (25) for NovoCure Ltd. is (12.06 - 13.4), which suggest NovoCure Ltd. is a Buy
-
The Bollinger Bands (100) for NovoCure Ltd. is (11.72 - 13.56), which suggest NovoCure Ltd. is a Buy
* NovoCure Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.